Federated Hermes Inc. Has $32.04 Million Position in ICU Medical, Inc. (NASDAQ:ICUI)

Federated Hermes Inc. lowered its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 206,467 shares of the medical instruments supplier's stock after selling 23,205 shares during the period. Federated Hermes Inc. owned 0.84% of ICU Medical worth $32,037,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the stock. Norges Bank acquired a new stake in shares of ICU Medical in the 4th quarter valued at $40,151,000. FMR LLC boosted its holdings in ICU Medical by 2,676.6% in the third quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock valued at $18,968,000 after acquiring an additional 100,345 shares during the last quarter. State Street Corp increased its position in ICU Medical by 9.3% in the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock worth $165,384,000 after purchasing an additional 77,506 shares during the period. Raymond James Financial Inc. bought a new stake in ICU Medical during the 4th quarter worth about $10,003,000. Finally, JPMorgan Chase & Co. lifted its position in ICU Medical by 7.4% during the 4th quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier's stock valued at $109,920,000 after purchasing an additional 49,108 shares during the period. Institutional investors own 96.10% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on ICUI shares. Raymond James set a $97.00 price target on shares of ICU Medical in a research report on Wednesday, March 12th. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Friday, April 4th. Finally, Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $168.67.

Remove Ads

ICU Medical Trading Up 3.0 %

NASDAQ ICUI traded up $4.22 during trading on Friday, reaching $142.65. 318,377 shares of the stock traded hands, compared to its average volume of 269,382. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The firm has a market cap of $3.50 billion, a price-to-earnings ratio of -31.21 and a beta of 0.86. The stock's 50-day moving average price is $148.29 and its 200 day moving average price is $160.86.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.